Preventive treatment in migraine and the new US guidelines

References

• Headache Classification Subcommittee of the International Headache SocietyThe International Classification of Headache Disorders, 2nd edCephalalgia200424Suppl 1916014979299
   PubMed Web of Science ®Google Scholar
• StewartWFShechterARasmussenBKMigraine prevalence. A review of population-based studiesNeurology1994446 Suppl 4S17S238008222
   PubMed Web of Science ®Google Scholar
• HuXHMarksonLELiptonRBStewartWFBergerMLBurden of migraine in the United States: disability and economic costsArch Intern Med1999159881381810219926
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEDiamondMFreitagFReedMLStewartWFMigraine prevalence, disease burden, and the need for preventive therapyNeurology200768534334917261680
   PubMed Web of Science ®Google Scholar
• OlesenJBousserMGDienerHCHeadache Classification CommitteeNew appendix criteria open for a broader concept of chronic migraineCephalalgia200626674274616686915
   PubMed Web of Science ®Google Scholar
• Gursoy-OzdemirYQiuJMatsuokaNCortical spreading depression activates and upregulates MMP-9J Clin Invest2004113101447145515146242
   PubMed Web of Science ®Google Scholar
• LeaoAAPSpreading depression of activity in the cerebral cortexJ Neurophysiol19447359390
   Google Scholar
• BusijaDWBariFDomokiFHoriguchiTShimizuKMechanisms involved in the cerebrovascular dilator effects of cortical spreading depressionProg Neurobiol200886437939518835324
   PubMed Web of Science ®Google Scholar
• BursteinRCollinsBJakubowskiMDefeating migraine pain with triptans: a race against the development of cutaneous allodyniaAnn Neurol2004551192614705108
   PubMed Web of Science ®Google Scholar
• PeroutkaSJDevelopments in 5-hydroxytriptamine receptor pharmacologyMathewNTHeadache neurologic clinics8Philadelphia, PA, USAWB Saunders Company1990829830839
   Google Scholar
• SilbersteinSDGoadsbyPJMigraine: preventive treatmentCephalalgia200222749151212230591
   PubMed Web of Science ®Google Scholar
• SilbersteinSDLiptonRBGoadsbyPJHeadache in Clinical Practice2nd edLondonInforma Healthcare2002Chapter 1692
   Google Scholar
• BigalMESerranoDBuseDScherAStewartWFLiptonRBAcute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based studyHeadache20084881157116818808500
   PubMed Web of Science ®Google Scholar
• AyataCJinHKudoCDalkaraTMoskowitzMASuppression of cortical spreading depression in migraine prophylaxisAnn Neurol200659465266116450381
   PubMed Web of Science ®Google Scholar
• HeningerFRCharneyDSMechanism of action of antidepressant treatments: implications for the etiology and treatment of depressive disordersMeltzerHYPsychopharmacology: The Third Generation of ProgressNew York, NYRaven Press1987535544
   Google Scholar
• PeroutkaSJDevelopments in 5-hydroxytriptamine receptor pharmacologyMathewNTHeadache. neurologic clinics8Philadelphia, PAWB Saunders Company1990829830839
   Google Scholar
• MiljanichGPRamachandranJAntagonists of neuronal calcium channels: structure, function, and therapeutic implicationsAnnu Rev Pharmacol Toxicol1995357077347598513
   PubMed Web of Science ®Google Scholar
• AbladBDahlofCMigraine and beta-blockade: modulation of sympathetic neurotransmissionCephalalgia19866Suppl 57132879634
   PubMed Web of Science ®Google Scholar
• TronvikEStovnerLJHeldeGSandTBovimGProphylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trialJAMA20032891656912503978
   PubMed Web of Science ®Google Scholar
• MathewNTRapoportASaperJEfficacy of gabapentin in migraine prophylaxisHeadache200141211912811251695
   PubMed Web of Science ®Google Scholar
• ShankRPGardockiJFStreeterAJMaryanoffBEAn overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionEpilepsia200041Suppl 1S3S910768292
   PubMed Web of Science ®Google Scholar
• CutrerFMLimmrothVMoskowitzMAPossible mechanisms of valproate in migraine prophylaxisCephalalgia1997172931009137844
   PubMed Web of Science ®Google Scholar
• MoskowitzMANeurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends Pharmacol Sci19921383073111329294
   PubMed Web of Science ®Google Scholar
• MauskopAAlturaBTCraccoRQAlturaBMDeficiency in serum ionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratioHeadache19933331351388486510
   PubMed Web of Science ®Google Scholar
• TepperSJBigalMRapoportASheftellFAlternative therapies: evidence-based evaluation in migraineHeadache Care200632–35764
   Google Scholar
• SheftellFRapoportAWeeksRWalkerBGammermanIBaskinSMontelukast in the prophylaxis of migraine: a potential role for leukotriene modifiersHeadache200040215816310759916
   PubMed Web of Science ®Google Scholar
• SandorPSDi ClementeLCoppolaGEfficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trialNeurology200564471371515728298
   PubMed Web of Science ®Google Scholar
• SchoenenJJacquyJLenaertsMEffectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trialNeurology19985024664709484373
   PubMed Web of Science ®Google Scholar
• SilbersteinSDPractice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of NeurologyNeurology200055675476210993991
   PubMed Web of Science ®Google Scholar
• SilbersteinSDHollandSFreitagFDodickDWArgoffCAshmanEEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American Academy of Neurology and the American Headache SocietyNeurology201278171337134522529202
   PubMed Web of Science ®Google Scholar
• HollandSSilbersteinSDFreitagFDodickDWArgoffCAshmanEEvidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the quality standards subcommittee of the American Academy of Neurology and the American Headache SocietyNeurology201278171346135322529203
   PubMed Web of Science ®Google Scholar
• GuptaPSinghSGoyalVShuklaGBehariMLow-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study)Headache200747340241217371357
   PubMed Web of Science ®Google Scholar
• AshtariFShaygannejadVAkbariMA double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxisActa Neurol Scand2008118530130518713156
   PubMed Web of Science ®Google Scholar
• Millan-GuerreroROIsais-MillanRBarreto-VizcainoSSubcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind studyEur Neurol200859523724218264012
   PubMed Web of Science ®Google Scholar
• BrandesJLSaperJRDiamondMTopiramate for migraine prevention: a randomized controlled trialJAMA2004291896597314982912
   PubMed Web of Science ®Google Scholar
• DienerHCTfelt-HansenPDahlofCTopiramate in migraine prophylaxis – results from a placebo-controlled trial with propranolol as an active controlJ Neurol2004251894395015316798
   PubMed Web of Science ®Google Scholar
• ShaygannejadVJanghorbaniMGhorbaniAAshtaryFZakizadeNNasrVComparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover studyHeadache200646464264816643559
   PubMed Web of Science ®Google Scholar
• DodickDWFreitagFBanksJTopiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineursClin Ther200931354255919393844
   PubMed Web of Science ®Google Scholar
• KeskinboraKAydinliIA double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraineClin Neurol Neurosurg20081101097998418620801
   PubMed Web of Science ®Google Scholar
• MeiDCapuanoAVollonoCTopiramate in migraine prophylaxis: a randomised double-blind versus placebo studyNeurol Sci200425524525015624081
   PubMed Web of Science ®Google Scholar
• SilbersteinSDNetoWSchmittJJacobsDMIGR-001 Study GroupTopiramate in migraine prevention: results of a large controlled trialArch Neurol200461449049515096395
   PubMedGoogle Scholar
• FreitagFGCollinsSDCarlsonHAA randomized trial of divalproex sodium extended-release tablets in migraine prophylaxisNeurology200258111652165912058094
   PubMed Web of Science ®Google Scholar
• SilbersteinSDCollinsSDSafety of divalproex sodium in migraine prophylaxis: an open-label, long-term studyHeadache199939963364311284461
   PubMedGoogle Scholar
• JoffeHCohenLSSuppesTValproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorderBiol Psychiatry200659111078108616448626
   PubMed Web of Science ®Google Scholar
• SilbersteinSSaperJBerensonFSomogyiMMcCagueKD’SouzaJOxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled studyNeurology200870754855518268247
   PubMed Web of Science ®Google Scholar
• SaperJRSilbersteinSDLakeAE3rdWintersMEDouble-blind trial of fluoxetine: chronic daily headache and migraineHeadache19943494975028002320
   PubMed Web of Science ®Google Scholar
• OzyalcinSNTaluGKKiziltanEYucelBErtasMDisciRThe efficacy and safety of venlafaxine in the prophylaxis of migraineHeadache200545214415215705120
   PubMed Web of Science ®Google Scholar
• BulutSBerilgenMSBaranATekatasAAtmacaMMungenBVenlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover studyClin Neurol Neurosurg20041071444815567552
   PubMed Web of Science ®Google Scholar
• SchraderHStovnerLJHeldeGSandTBovimGProphylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover studyBMJ20013227277192211141144
   PubMed Web of Science ®Google Scholar
• DienerHCGendollaAFeuersengerATelmisartan in migraine prophylaxis: a randomized, placebo-controlled trialCephalalgia200929992192719250283
   PubMed Web of Science ®Google Scholar
• DienerHCHartungEChrubasikJA comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III studyCephalalgia200121212012811422094
   PubMed Web of Science ®Google Scholar
• SchellenbergRLichtenthalAWohlingHGrafCBrixiusKNebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?Headache200848111812518184294
   PubMed Web of Science ®Google Scholar
• RaoBSDasDGTaraknathVRSarmaYA double blind controlled study of propranolol and cyproheptadine in migraine prophylaxisNeurol India200048322322611025624
   PubMed Web of Science ®Google Scholar
• SilbersteinSDElkindAHSchreiberCKeywoodCA randomized trial of frovatriptan for the intermittent prevention of menstrual migraineNeurology200463226126915277618
   PubMed Web of Science ®Google Scholar
• BrandesJLPooleAKallelaMShort-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacksCephalalgia200929111133114819811503
   PubMed Web of Science ®Google Scholar
• Millan-GuerreroROIsais-MillanRBarreto-VizcainoSSubcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind studyEur J Neurol200714101079108417880560
   PubMed Web of Science ®Google Scholar
• NewmanLMannixLKLandySNaratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled studyHeadache200141324825611264684
   PubMed Web of Science ®Google Scholar
• TuchmanMMHeeAEmeribeUSilbersteinSOral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled studyCNS Drugs2008221087788618788838
   PubMed Web of Science ®Google Scholar
• Millan-GuerreroROIsais-MillanRBenjaminTHTeneCEN-alpha-methyl histamine safety and efficacy in migraine prophylaxis: phase III studyCan J Neurol Sci200633219519916736729
   PubMed Web of Science ®Google Scholar
• BrandesJLVisserWHFarmerMVMontelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled studyHeadache200444658158615186302
   PubMed Web of Science ®Google Scholar
• BensenorIMCookNRLeeIMChownMJHennekensCHBuringJELow-dose aspirin for migraine prophylaxis in womenCephalalgia200121317518311442551
   PubMed Web of Science ®Google Scholar
• SilbersteinSDOlesenJBousserMGThe International Classification of Headache Disorders, 2nd edition (ICHD-II) – revision of criteria for 8.2 medication-overuse headacheCephalalgia200525646046515910572
   PubMed Web of Science ®Google Scholar
• BigalMERapoportAMSheftellFDTransformed migraine and medication overuse in a tertiary headache centre—clinical characteristics and treatment outcomesCephalalgia20042448349015154858
   PubMed Web of Science ®Google Scholar
• GrossmanWSchmidramslHAn extract of Petasites hybridus is effective in the prophylaxis of migraineAltern Med Rev20016330331011410074
   PubMedGoogle Scholar
• LiptonRBGobelHEinhauplKMWilksKMauskopAPetasites hybridus root (butterbur) is an effective preventive treatment for migraineNeurology200463122240224415623680
   PubMed Web of Science ®Google Scholar
• EftedalOSLydersenSHeldeGWhiteLBrubakkAOStovnerLJA randomized, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraineCephalalgia200424863964415265052
   PubMed Web of Science ®Google Scholar
• MacGregorEAFrithAEllisJAspinallLHackshawAPrevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover studyNeurology200667122159216317190936
   PubMed Web of Science ®Google Scholar
• MaizelsMBlumenfeldABurchetteRA combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trialHeadache200444988589015447697
   PubMed Web of Science ®Google Scholar
• PfaffenrathVDienerHCFischerMFriedeMHenneicke-von ZepelinHHThe efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis – a double-blind, multicentre, randomized placebo-controlled dose-response studyCephalalgia200222752353212230594
   PubMed Web of Science ®Google Scholar
• DienerHCPfaffenrathVSchnitkerJFriedeMHenneicke-von ZepelinHHEfficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention – a randomized, double-blind, multicentre, placebo-controlled studyCephalalgia200525111031104116232154
   PubMed Web of Science ®Google Scholar
• PradalierABakouchePBaudessonGFailure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placeboCephalalgia200121881882211737007
   PubMed Web of Science ®Google Scholar
• PringsheimTDavenportWMackieGCanadian Headache Society guideline for migraine prophylaxisCan J Neurol Sci2012392 Suppl 2S1S5922683887
   PubMed Web of Science ®Google Scholar
• LiptonRBSilbersteinSDSaperJRBigalMEGoadsbyPJWhy headache treatment failsNeurology20036071064107012682307
   PubMed Web of Science ®Google Scholar